These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25637424)

  • 41. Safety of copper T as contraceptive after caesarean section.
    Parikh V; Gandhi AS
    J Indian Med Assoc; 1989 May; 87(5):113-5. PubMed ID: 2600433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anaemia and menstrual blood loss studies in women using multiload Cu250 and progestasert IUDs.
    Goh TH; Hariharan M; Chan GL
    Contraception; 1984 Apr; 29(4):359-66. PubMed ID: 6744857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of iron deficiency anemia in IUD users by prostaglandin synthetase inhibitors.
    Blum M; Pery J
    Contracept Deliv Syst; 1984 Jan; 5(1):21-3. PubMed ID: 12312741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
    Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
    J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen.
    Hubacher D; Reyes V; Lillo S; Pierre-Louis B; Zepeda A; Chen PL; Croxatto H
    Hum Reprod; 2006 Jun; 21(6):1467-72. PubMed ID: 16484309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of baseline menstrual bleeding pattern on copper intrauterine device continuation.
    Hobby JH; Zhao Q; Peipert JF
    Am J Obstet Gynecol; 2018 Nov; 219(5):465.e1-465.e5. PubMed ID: 30170037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bleeding, cramping, and satisfaction among new copper IUD users: A prospective study.
    Sanders JN; Adkins DE; Kaur S; Storck K; Gawron LM; Turok DK
    PLoS One; 2018; 13(11):e0199724. PubMed ID: 30403671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fetal Candida infection associated with an intrauterine contraceptive device.
    Marelli G; Mariani A; Frigerio L; Leone E; Ferrari A
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):209-12. PubMed ID: 8886709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.
    Gonçalves B; Ferreira C; Alves CT; Henriques M; Azeredo J; Silva S
    Crit Rev Microbiol; 2016 Nov; 42(6):905-27. PubMed ID: 26690853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adhesion and biofilm formation of Candida parapsilosis isolated from vaginal secretions to copper intrauterine devices.
    Borges KRA; Pimentel IV; Lucena LCLDS; Silva MACND; Monteiro SG; Monteiro CA; Nascimento MDDSB; Bezerra GFB
    Rev Inst Med Trop Sao Paulo; 2018 Oct; 60():e59. PubMed ID: 30365642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of a copper-intrauterine device on the uterine artery blood flow in regularly menstruating women.
    Järvelä I; Tekay A; Jouppila P
    Hum Reprod; 1998 Jul; 13(7):1841-5. PubMed ID: 9740436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can uterine artery Doppler parameters predict copper intrauterine device-induced side effects?
    Mutlu I; Demir A; Mutlu MF
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):51-6. PubMed ID: 24341777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections.
    Ferraz do Lago R; Simões JA; Bahamondes L; Camargo RP; Perrotti M; Monteiro I
    Contraception; 2003 Aug; 68(2):105-9. PubMed ID: 12954522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Side effects from the copper IUD: do they decrease over time?
    Hubacher D; Chen PL; Park S
    Contraception; 2009 May; 79(5):356-62. PubMed ID: 19341847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of copper intrauterine device on the cyclooxygenase and inducible nitric oxide synthase expression in the luteal phase endometrium.
    Coskun E; Cakiroglu Y; Aygun BK; Muezzinoglu B; Caliskan E
    Contraception; 2011 Dec; 84(6):637-41. PubMed ID: 22078195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids.
    Farhan MA; Moharram AM; Salah T; Shaaban OM
    Med Mycol; 2019 Aug; 57(6):681-687. PubMed ID: 30544194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Candida vulvovaginitis: A store with a buttery and a show window.
    Donders GG; Sobel JD
    Mycoses; 2017 Feb; 60(2):70-72. PubMed ID: 27687503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review.
    Tepper NK; Steenland MW; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):639-44. PubMed ID: 23040123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.